Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy

MLA

Maren Freigang, et al. “Increased Chitotriosidase 1 Concentration Following Nusinersen Treatment in Spinal Muscular Atrophy.” Orphanet Journal of Rare Diseases, vol. 16, no. 1, July 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13023-021-01961-8.

APA

Maren Freigang, Petra Steinacker, Claudia Diana Wurster, Olivia Schreiber-Katz, Alma Osmanovic, Susanne Petri, Jan Christoph Koch, Kevin Rostásy, Björn Falkenburger, Albert Christian Ludolph, Markus Otto, Andreas Hermann, & René Günther. (2021). Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy. Orphanet Journal of Rare Diseases, 16(1), 1–11. https://doi.org/10.1186/s13023-021-01961-8

Chicago

Maren Freigang, Petra Steinacker, Claudia Diana Wurster, Olivia Schreiber-Katz, Alma Osmanovic, Susanne Petri, Jan Christoph Koch, et al. 2021. “Increased Chitotriosidase 1 Concentration Following Nusinersen Treatment in Spinal Muscular Atrophy.” Orphanet Journal of Rare Diseases 16 (1): 1–11. doi:10.1186/s13023-021-01961-8.